AI and Deep Learning in Drug Development and Healthcare?

I would be very surprised if within the next three years we wouldn't actually start to see an inclination point happening when it comes to machine learning, large-scale deep learning in drug development and drug design. Where exactly they'll be first, of course, I believe that a lot of them will happen around RNA, RNA therapeutics and vaccines. It's something that can be produced fairly effectively. There are some challenges there, but synthesis is something that can scale and is scaling rapidly. And these things come together really to enable this rapid feedback loop that I guess is often alluded to, but very rarely, at least from what I know, actually implemented and implementable at the end of the day